rethinkPeptides Search
Menu
Research citation

Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study.

Vaccine, 30(6), 1170-80

Citation

Carraro, G; Naso, A; Montomoli, E; Gasparini, R; Camerini, R; Panatto, D; Tineo, M C; De Giorgi, L; Piccirella, S; Khadang, B; Ceracchi, M; De Rosa, A. (2012). Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study.. Vaccine, 30(6), 1170-80. https://doi.org/10.1016/j.vaccine.2011.12.014